Welcome to our dedicated page for Balchem news (Ticker: BCPC), a resource for investors and traders seeking the latest updates and insights on Balchem stock.
Balchem Corporation reports developments tied to its specialty ingredient manufacturing business for health, nutrition, agriculture, healthcare, and other industrial markets. The company operates through Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products, with recurring updates on segment sales, earnings, cash flow, debt, share repurchases, and conference participation.
Company news also includes product and market developments such as customized food and beverage ingredient systems, key nutrients for food, supplement, and pharmaceutical applications, animal nutrition products, choline chloride, specialty-packaged chemicals, and chelated minerals for micronutrient agriculture. Updates have included the Metalosate® T.E.A.M.™ plant tissue analysis platform and trade actions affecting choline chloride supply chains.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Balchem Corporation (NASDAQ: BCPC) has announced a conference call scheduled for April 28, 2023, at 11:00 AM ET to discuss its first-quarter results. Results will be publicly released before the market opens on the same day. The call will be led by CEO Ted Harris and CFO Martin Bengtsson, and will be available for replay until May 12, 2023. Interested parties can join the call by dialing 1-877-407-8289 or 1-201-689-8341. Balchem operates across three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products, focusing on developing specialty ingredients to enhance health and well-being across various industries worldwide.
Balchem Corporation (NASDAQ: BCPC) reported impressive fourth quarter financial results for 2022, with net sales of $232.5 million, up 9.1% from $213.1 million in Q4 2021. However, net earnings decreased to $21.4 million from $24.9 million, although adjusted net earnings rose to $30.3 million from $27.8 million. For the full year, net sales increased 17.9% to a record $942.4 million, while net earnings rose 9.6% to $105.4 million. The company achieved record sales across all three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. Balchem also maintained a strong cash flow and continues to focus on strategic growth initiatives.
Balchem Corporation (NASDAQ: BCPC) will hold a conference call on February 24, 2023, at 11:00 AM ET to discuss its fourth quarter results. These results will be released before the market opens on the same day. The call will be hosted by Ted Harris (CEO) and Martin Bengtsson (CFO). Investors can join by dialing 1-877-407-8289, and the session will be available for replay until March 10, 2023. Balchem specializes in developing and marketing specialty ingredients across Human Nutrition, Animal Nutrition, and Specialty Products sectors, aiming to enhance health and well-being globally.
Summary not available.
Balchem Corporation (NASDAQ: BCPC) CFO Martin Bengtsson will present at the CJS Securities 23rd Annual "New Ideas for the New Year" Investor Conference on January 11, 2023, starting at 11:00 AM EST. The presentation will be accessible on Balchem's website post-conference. Balchem specializes in developing and marketing ingredients that enhance health and well-being across various industries, with three main segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products.